Christian J. Wiedermann, M.D.
Christian J. Wiedermann, M.D.
UMIT - The Health and Life Sciences University, Hall i.T., Austria
E-mail confirmado em
Citado por
Citado por
Toll-like receptor 4 polymorphisms and atherogenesis
S Kiechl, E Lorenz, M Reindl, CJ Wiedermann, F Oberhollenzer, E Bonora, ...
New England Journal of Medicine 347 (3), 185-192, 2002
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study
S Kiechl, G Egger, M Mayr, CJ Wiedermann, E Bonora, F Oberhollenzer, ...
Circulation 103 (8), 1064-1070, 2001
Lipoprotein-associated phospholipase A (2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
A Thompson, P Gao, L Orfei, S Watson, EA Di, S Kaptoge, C Ballantyne, ...
Lancet (London, England) 375 (9725), 1536-1544, 2010
Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study
CJ Wiedermann, S Kiechl, S Dunzendorfer, P Schratzberger, G Egger, ...
Journal of the American College of Cardiology 34 (7), 1975-1981, 1999
Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
J Kienast, M Juers, CJ Wiedermann, JN Hoffmann, H Ostermann, ...
Journal of Thrombosis and Haemostasis 4 (1), 90-97, 2006
Oxidized phospholipids, lipoprotein (a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study
S Kiechl, J Willeit, M Mayr, B Viehweider, M Oberhollenzer, F Kronenberg, ...
Arteriosclerosis, thrombosis, and vascular biology 27 (8), 1788-1795, 2007
Antithrombin: a new look at the actions of a serine protease inhibitor
J Roemisch, E Gray, JN Hoffmann, CJ Wiedermann
Blood coagulation & fibrinolysis 13 (8), 657-670, 2002
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety
CJ Wiedermann, JN Hoffmann, M Juers, H Ostermann, J Kienast, ...
Critical care medicine 34 (2), 285-292, 2006
Expression and function of the endothelial protein C receptor in human neutrophils
DH Sturn, NC Kaneider, C Feistritzer, A Djanani, K Fukudome, ...
Blood 102 (4), 1499-1505, 2003
Increased expression of CCL20 in human inflammatory bowel disease
A Kaser, O Ludwiczek, S Holzmann, AR Moschen, G Weiss, B Enrich, ...
Journal of clinical immunology 24 (1), 74-85, 2004
Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study
S Tsimikas, J Willeit, M Knoflach, M Mayr, G Egger, M Notdurfter, ...
European heart journal 30 (1), 107-115, 2009
Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies
CJ Wiedermann, W Wiedermann, M Joannidis
Intensive care medicine 36 (10), 1657-1665, 2010
Induction of circulating IL-1 receptor antagonist by IFN treatment.
H Tilg, JW Mier, W Vogel, WE Aulitzky, CJ Wiedermann, E Vannier, ...
The Journal of Immunology 150 (10), 4687-4692, 1993
Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells.
P Schratzberger, N Reinisch, WM Prodinger, CM Kähler, BA Sitte, ...
The Journal of Immunology 158 (8), 3895-3901, 1997
Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis
CJ Wiedermann
BMC emergency medicine 8 (1), 1, 2008
Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin
CJ Wiedermann, N Reinisch, H Braunsteiner
Attraction of human monocytes by the neuropeptide secretoneurin
N Reinisch, R Kirchmair, CM Kähler, R Hogue-Angeletti, ...
FEBS letters 334 (1), 41-44, 1993
Migration of human monocytes in response to procalcitonin
FJ Wiedermann, N Kaneider, P Egger, W Tiefenthaler, CJ Wiedermann, ...
Critical care medicine 30 (5), 1112-1117, 2002
Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials
CJ Wiedermann, S Dunzendorfer, LU Gaioni, F Zaraca, M Joannidis
Critical Care 14 (5), R191, 2010
Marburg I polymorphism of factor VII–activating protease: a prominent risk predictor of carotid stenosis
J Willeit, S Kiechl, T Weimer, A Mair, P Santer, CJ Wiedermann, ...
Circulation 107 (5), 667-670, 2003
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20